|
|
|
| home > white papers > Analysis of Biopharmaceuticals to Conform to ICHQ6B - RSSL |
|
|
 WHITE PAPERS |
|
RSSL
|
+44 (0)118 918 4024
|
|
http://www.rssl.com
|
|
University of Reading, Whiteknights Rd, Reading, West Berkshire RG6 6LA
|
|
|
Analysis of Biopharmaceuticals to Conform to ICHQ6B
|
|
Worldwide, the pharmaceuticals market is anticipated to grow from more
than USD 782 billion in 2011 to approach a value of just over USD 971
billion by the end of 2016, registering a CAGR of over 24%. In 2010 the
average medicines expenditure per person within the UK was £271, and
this is expected to increase with the ageing population. A significant
and increasing proportion of these sales are protein-based
biotherapeutics or biomolecules. Currently, these account for 19% of the
total market, and are growing at twice the rate of traditional small
molecule pharmaceuticals. It is predicted that close to 50% of the top
100 pharmaceutical products will be biomolecules by 2016. By far the
largest segment of the biopharmaceutical market is the monoclonal
antibody (MAb) with an estimated share of 25.6%, which corresponds to
USD 51.1 billion.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Turkish Cargo adds Kuala Lumpur and Ahmedabad to its cargo flight network.
The fastest growing global air cargo brand Turkish Cargo continues to
expand its cargo flight network. The successful air cargo carrier has
added Malaysian capital Kuala Lumpur (KUL) and the western Indian city
of Ahmedabad (AMD) among the destinations to which it performs direct
cargo flights.
More info >> |
|
 |
White Papers |
 |
|
 |
Industry Events |
 |
2020 Avoca Quality and Innovation Summit
3-4 June 2020, Amsterdam, The Netherlands
The 2020 Avoca Quality and Innovation Summit will take place 3-4 June
2020, in Amsterdam, The Netherlands.
More info >> |
|
|
|
